These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 11192133
21. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study. Quinn J, Ruoff GE, Ziter PS. Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505 [Abstract] [Full Text] [Related]
22. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis. McCarty JM, Pierce PF. Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426 [Abstract] [Full Text] [Related]
23. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. Anzueto A, Niederman MS, Tillotson GS. Clin Ther; 1998 Oct; 20(5):885-900. PubMed ID: 9829441 [Abstract] [Full Text] [Related]
24. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults. Drehobl MA, De Salvo MC, Lewis DE, Breen JD. Chest; 2005 Oct; 128(4):2230-7. PubMed ID: 16236879 [Abstract] [Full Text] [Related]
26. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients. Takker U, Dzyublyk O, Busman T, Notario G. Curr Med Res Opin; 2003 Jun; 19(5):421-9. PubMed ID: 13678479 [Abstract] [Full Text] [Related]
27. [Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis]. Perronne C, Drugeon H, Zuck P, Filipecki J, Vincent-Lacaze N, Goldfarb G, Léophonte P. Med Mal Infect; 2005 Oct; 35(10):507-15. PubMed ID: 16239090 [Abstract] [Full Text] [Related]
28. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D. Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475 [Abstract] [Full Text] [Related]
29. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis. Hosie J, Quinn P, Smits P, Sides G. J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264 [Abstract] [Full Text] [Related]
30. Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis. Gotfried MH, DeAbate CA, Fogarty C, Mathew CP, Sokol WN. Clin Ther; 2001 Jan; 23(1):97-107. PubMed ID: 11219483 [Abstract] [Full Text] [Related]
31. Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis. Ziering W, McElvaine P. Infection; 1998 Jan; 26(1):68-75. PubMed ID: 9505188 [Abstract] [Full Text] [Related]
32. Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections. Allin D, James I, Zachariah J, Carr W, Cullen S, Middleton A, Newson P, Lytle T, Coles S. Clin Ther; 2001 Dec; 23(12):1958-68. PubMed ID: 11813931 [Abstract] [Full Text] [Related]
33. Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG). Khan S, Javaid A, Ghori RA, Mahmood K, Anwer N, Khan SU, Iqbal ZH, Rahman F, Ullah S, Imran K, Akhter N, Khan MK, Siddqui SJ, Fareed A, Khan MH. J Pak Med Assoc; 2003 Aug; 53(8):338-45. PubMed ID: 14558738 [Abstract] [Full Text] [Related]
34. Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis. Adam D. Infection; 1993 Aug; 21(4):265-71. PubMed ID: 8225636 [Abstract] [Full Text] [Related]
35. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA. Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [Abstract] [Full Text] [Related]
36. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. Neu HC, Chick TW. Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794 [Abstract] [Full Text] [Related]